Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2026-04-28 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
2025年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2025年度董事会工作报告' which translates to '2025 Annual Board of Directors Work Report'. It details the board's activities, meetings, resolutions, governance, and plans for the next year. It includes financial performance summaries but does not contain full financial statements or detailed financial data typical of an Annual Report (10-K) or Interim Report (IR). The document focuses on the board's work, governance, and oversight activities rather than comprehensive financial results. It also references the board's compliance with laws and governance rules, and the execution of shareholder meeting resolutions. This aligns with the category 'Board/Management Information (MANG)', which covers announcements of changes or reports related to the company's board or senior management activities. The document length is about 4878 characters, which is sufficient for a detailed board report but not a full annual report. Therefore, the best classification is MANG with high confidence.
2026-04-28 Chinese
关于变更持续督导保荐代表人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change of continuous supervision sponsor representatives for a company listed on the Beijing Stock Exchange. It details personnel changes in the sponsor representatives and includes a brief resume attachment. There is no financial data, no report content, and no mention of voting results or dividends. The document is about management changes related to sponsor representatives, which aligns with announcements about changes in company management or board-related roles. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2026-04-20 Chinese
股权质押的公告
Regulatory Filings Classification · 82% confidence The document is an announcement of an equity pledge (‘股权质押’) by a controlling shareholder, detailing the number of shares pledged, pledgees, terms, and related historical pledges. It is not an annual or interim report, earnings release, management or board change, dividend notice, or M&A document. Nor is it a share issuance or buyback by the company itself. It is a standalone regulatory announcement that does not fit any specialized category, so it falls under the general Regulatory Filings category (RNS).
2026-04-14 Chinese
关于子公司部分债务逾期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Kangle Weishi Biotechnology Co., Ltd. regarding overdue debt of its subsidiary. It details the overdue loan amount, the impact on the company including financial risks and potential legal risks, and the company's plans to negotiate and manage the situation. The document is a regulatory announcement about a financial risk event, not a full financial report, audit, or earnings release. It does not contain financial statements or detailed financial data, nor is it a report publication announcement. It fits best under Regulatory Filings (RNS) as a general regulatory announcement about a material event affecting the company.
2026-03-31 Chinese
关于股东部分股权解除质押和质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge and release of pledged shares by a major shareholder (天狼星控股集团有限公司) of the company 北京康乐卫士生物技术股份有限公司. It details the number of shares pledged and released, the dates, the pledgees, and the impact on control of the company. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging activities, which fits the category of Major Shareholding Notification (MRQ) as it involves changes in significant share ownership levels and pledging status by a controlling shareholder.
2026-03-25 Chinese
2025年年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2025 年年度业绩快报公告" which translates to "2025 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2025, including revenue, profit, assets, and equity figures. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be disclosed in the company's 2025 annual report. The document is relatively short (1879 characters) and serves as a brief announcement of preliminary financial results rather than a full annual report. It also includes a risk warning and a statement that the detailed audited report will be published later. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only, not the full detailed report. Therefore, the correct classification is Earnings Release (ER). FY 2025
2026-02-26 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.